Couverture de Teplizumab: Hit Snooze on Type 1

Teplizumab: Hit Snooze on Type 1

Teplizumab: Hit Snooze on Type 1

Écouter gratuitement

Voir les détails

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce contenu audio

There's been a crazy breakthrough in type 1 diabetes healthcare. If you're screened early enough, there's a drug that can hit pause on type 1 diabetes before you're ever symptomatic. It's not a cure, but it can delay diagnosis by years. Nuts, right???

Not so helpful for those of us who've been diabetic for years. But great news for future diabetics, especially little kids.

In this episode, Dr Tracy explains this new drug (Teplimuzab), how it works, and who can actually get it. We also get honest about the price tag, and then ask the big question: if we could go back in time and be prepared for diagnosis, would we do it?

What we cover:

💉 What is Teplimuzab? How does it work?

🔍 Who qualifies?

💸 The healthcare economics (this stuff ain't cheap!)

⏪ What we would do if we could go back in time.

We love it when listeners say hi. Drop us a text.

Email cait@correctiondose.com
Visit correctiondose.com
Find us on Instagram @type1tracy or @correctiondose

This content in this podcast is for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider before making any changes to your diabetes management or treatment plan.

adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment